Event Speakers

Reproducibility in biomedical research is fundamental, yet complex systemic challenges derail many efforts to reproduce important studies. Solutions are equally complex, calling for changes in all aspects of research practice, from how experiments are performed to how data are analyzed and shared.

Scientific standards play a robust role in research reproducibility. Stakeholders from academia, industry, government, and scientific journals will come together to build and reinforce standards to enhance reproducibility. Scientific experts will address the unique standards needs for specific fields.

Accepted Speakers 

Keynote

• Harvey V. Fineberg, MD, Ph.D., President, Gordon and Betty Moore Foundation 

Reproducibility of Biomedical Research: Challenges and Opportunities 

• Jesse Boehm, Ph.D., Principal Investigator, Koch Institute of MIT, Chief Science Officer, Break Through Cancer
• Rodney Rouse, DVM, MBA, Ph.D., Acting Director, Division of Applied Regulatory Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration  
• Derek Lowe, Ph.D., Director in Chemical Biology & Therapeutics, Novartis Institutes for Biomedical Research  
• Valda Vinson, Ph.D., Executive Editor, Science Journals
• Joshua LaBaer, MD, Ph.D., Executive Director and Professor, School of Molecular Sciences, Biodesign Institute, Arizona State University
• Sarine Markossian, Ph.D., Editor-in-Chief, Assay Guidance Manual (AGM); Lead, AGM Translational Science Resources Program, National Center for Advancing Translational Sciences 

One Size Does Not Fit All: Issues and Progress in Distinct Subject Matter Areas 

• Jeff Whiteaker, PhD, Director of Proteomics, Paulovich Lab, Fred Hutchinson Cancer Center
• Aled Edwards, PhD, Professor of Medical Genetics and Medical Biophysics, University of Toronto
• Joseph C. Wu, MD, PhD, Professor & Director of the Stanford Cardiovascular Institute, Stanford & Co-Founder, Greenstone Biosciences
• Rob Scharpf, PhD, Associate Professor, Johns Hopkins School of Medicine
• Sean Mooney, PhD, Director, Center for Information Technology, National Institutes of Health

Breakout Sessions

1. Antibody Characterization

• Andrew Chalmers, Ph.D., CEO, CiteAb
• Anita Bandrowski, Ph.D., CEO, SciCrunch; Lead, RRIDs.org
• Will Howat, Ph.D., Vice President, Validation & Technical Quality, Abcam
• Carl Laflamme, Ph.D., Group Leader, Structural Genomics Consortium, Montreal Neurological Institute (McGill University)
• Deborah Moshinsky, Ph.D., Director of Antibody Characterization and Validation, Institute for Protein Innovation
• Roberto Polakiewicz, Ph.D., Chief Scientific Officer, Cell Signaling Technology
• Simona Colantonio, Ph.D., Director, Antibody Characterization Laboratory, Frederick National Laboratory for Cancer Research

2. Reproducibility in Recombinant Protein Productions 

• Carter Mitchell, Ph.D., Chief Science Officer, Kemp Proteins
• Oleg Brodsky, MBA, Senior Principal Scientist, Pfizer  
• William Gillette, Ph.D., Associate Principal Scientist, Qiagen  
• Caroline DeHart, Ph.D., Group Leader, Mass Spectrometry, NCI RAS Initiative, Frederick National Laboratory for Cancer Research
• Aled Edwards, Ph.D., Professor of Medical Genetics and Medical Biophysics, University of Toronto
• Ruth Saxl, Ph.D., Senior Manager, Protein Sciences Service, The Jackson Laboratory   
• Carissa Grose, Interim Co-Director, Protein Expression Laboratory, Frederick National Laboratory for Cancer Research

3. Drug Discovery 

• Gurusingham Sitta Sittampalam, Ph.D., Adjunct Clinical Associate Professor of Medicine, Indiana University School of Medicine
• Madhu Lal-Nag, Ph.D., Chief Scientific Officer, InSphero
• Jim McGee, Ph.D., (Retired) Senior Director, Eli Lilly and Company
• Samarjit Patnaik, Ph.D., Chemistry Group Leader, National Center for Advancing Translational Sciences
• Terry Riss, Ph.D., Global Strategic Marketing Manager, Promega Corporation
• Thomas “TC” D.Y. Chung, Ph.D., Director, Translational Programs Outreach, Conrad Prebys Center for Chemical Genomics,
• Sanford Burnham Prebys Medical Discovery Institute
• Nathan P. Coussens, Ph.D., Scientific Director, Molecular Pharmacology Laboratory, Frederick National Laboratory for Cancer Research

4. Organoids  

• Stephen Jones, PhD, Director, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research

5: Ensuring Consistent and Reproducible Genomic Data from Liquid Biopsies  

• Joshua Xu, PhD, Branch Chief, Research-to-Review and Return, Division of Bioinformatics and Biostatistics, U.S. Food and Drug Administration  
• Jeff Allen, PhD, President & CEO, Friends of Cancer Research  
• Chris Karlovich, PhD, Director, Molecular Characterization Program, Frederick National Laboratory for Cancer Research

6: Best Practices and Solutions for Mitigating the Reproducibility Crisis in AI Science   

• Justin Kirby, Technical Director, Cancer Imaging Informatics Lab, Frederick National Laboratory for Cancer Research  
• Uma Mudunuri, PhD, Director, Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research